Jefferies Group’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-241,400
| Closed | -$42.8M | – | 2270 |
|
|
2020
Q1 | $42.8M | Sell |
241,400
-470,000
| -66% | -$88.5M | 0.47% | 18 |
|
|
2019
Q4 | $136M | Sell |
711,400
-26,400
| -4% | -$4.76M | 1.05% | 10 |
|
|
2019
Q3 | $124M | Buy |
737,800
+470,800
| +176% | +$76.7M | 0.96% | 3 |
|
|
2019
Q2 | $44.7M | Buy |
267,000
+251,300
| +1,601% | +$34.8M | 0.33% | 32 |
|
|
2019
Q1 | $2.3M | Sell |
15,700
-35,300
| -69% | -$5.12M | 0.02% | 844 |
|
|
2018
Q4 | $6.82M | Buy |
51,000
+36,200
| +245% | +$5.93M | 0.06% | 307 |
|
|
2018
Q3 | $2.82M | Sell |
14,800
-28,900
| -66% | -$5.31M | 0.02% | 817 |
|
|
2018
Q2 | $7.29M | Sell |
43,700
-2,300
| -5% | -$369K | 0.04% | 359 |
|
|
2018
Q1 | $7.74M | Sell |
46,000
-87,800
| -66% | -$14.7M | 0.04% | 318 |
|
|
2017
Q4 | $21.9M | Buy |
133,800
+35,400
| +36% | +$6.35M | 0.1% | 115 |
|
|
2017
Q3 | $20.2M | Buy |
98,400
+21,800
| +28% | +$5.07M | 0.13% | 121 |
|
|
2017
Q2 | $18.6M | Sell |
76,600
-35,600
| -32% | -$8.37M | 0.12% | 144 |
|
|
2017
Q1 | $26.8M | Sell |
112,200
-1,061,200
| -90% | -$247M | 0.2% | 75 |
|
|
2016
Q4 | $246M | Sell |
1,173,400
-1,047,500
| -47% | -$217M | 1.38% | 6 |
|
|
2016
Q3 | $511M | Buy |
2,220,900
+39,200
| +2% | +$9.58M | 2.64% | 4 |
|
|
2016
Q2 | $504M | Buy |
2,181,700
+135,900
| +7% | +$31.3M | 2.29% | 5 |
|
|
2016
Q1 | $548M | Buy |
2,045,800
+298,800
| +17% | +$85.5M | 3.16% | 4 |
|
|
2015
Q4 | $546M | Buy |
1,747,000
+1,611,700
| +1,191% | +$480M | 3.1% | 4 |
|
|
2015
Q3 | $36.8M | Buy |
135,300
+115,200
| +573% | +$35.4M | 0.21% | 82 |
|
|
2015
Q2 | $6.1M | Sell |
20,100
-1,258,200
| -98% | -$375M | 0.03% | 441 |
|
|
2015
Q1 | $380M | Buy |
1,278,300
+1,182,300
| +1,232% | +$337M | 2.12% | 6 |
|
|
2014
Q4 | $24.7M | Buy |
96,000
+65,500
| +215% | +$16.4M | 0.15% | 122 |
|
|
2014
Q3 | $7.36M | Sell |
30,500
-64,800
| -68% | -$14.5M | 0.05% | 312 |
|
|
2014
Q2 | $21.3M | Buy |
+95,300
| New | +$19.7M | 0.18% | 97 |
|
|
2013
Q3 | – | Sell |
-7,500
| Closed | -$947K | – | 2295 |
|
|
2013
Q2 | $947K | Buy |
+7,500
| New | +$849K | 0.01% | 804 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Jefferies Group's AGN Position: Q2 2020 in Review
Jefferies Group sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 269,542 shares — an estimated $47.7M sold.
Jefferies Group first reported a position in AGN in Q2 2014 and held it in 24 quarters. The position peaked at $81.1M in Q2 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Jefferies Group reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Jefferies Group sold 269,542 Allergan plc shares in Q2 2020, an estimated $47.7M.
- Jefferies Group first reported a position in Allergan plc in Q2 2014 and held it in 24 quarters.
- Jefferies Group's Allergan plc position peaked at $81.1M in Q2 2016.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Jefferies Group's 13F filing for Q2 2020, filed 14 Aug 2020.